Epstein-Barr Virus, Cytomegalovirus, and Other Viral Infections in Children After Liver Transplantatlon
MK Breinig, B Zitelli, TE Starzl… - Journal of Infectious …, 1987 - academic.oup.com
We studied 51 consecutive pediatric patients for the frequency and morbidity of viral
infections after liver transplantation. The incidence of primary (67%) and reactivation (48%) …
infections after liver transplantation. The incidence of primary (67%) and reactivation (48%) …
Viral and toxoplasma gondii infections in children after liver transplantation.
A Salt, G Sutehall, M Sargaison, C Woodward… - Journal of clinical …, 1990 - jcp.bmj.com
The incidence and morbidity of viral and Toxoplasma gondii infections were studied in 40
children who underwent liver transplantation between December 1983 and February 1988 …
children who underwent liver transplantation between December 1983 and February 1988 …
Cytomegalovirus infections in pediatric liver transplantation
SM King, M Petric, R Superina, N Graham… - American Journal of …, 1990 - jamanetwork.com
• From 1986 to 1989, 26 consecutive pediatric liver transplant recipients were followed up at
The Hospital for Sick Children, Toronto, Canada. The patients were reviewed to assess the …
The Hospital for Sick Children, Toronto, Canada. The patients were reviewed to assess the …
Infectious complications in living related liver transplantation
S Uemoto, K Tanaka, S Fujita, K Sano… - Journal of pediatric …, 1994 - Elsevier
During the last 31 months, 50 children between 3 months and 15 years of age have
undergone living related liver transplantation (LRLT) for end-stage liver diseases (39 biliary …
undergone living related liver transplantation (LRLT) for end-stage liver diseases (39 biliary …
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease
R Mañez, MC Breinig, P Linden, J Wilson… - Journal of Infectious …, 1997 - academic.oup.com
Epstein-Barr virus (EBV) plays a major role in the pathogenesis of posttransplant
lymphoproliferative disease (PTLD). Patients who undergo primary EBV infection after …
lymphoproliferative disease (PTLD). Patients who undergo primary EBV infection after …
Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients
EM SoKAL, T CARAGIOZOGLOU, M LAMY… - …, 1993 - journals.lww.com
Epstein-Barr virus aerology was performed before and after transplantation in 116 patients
of a total series of 261 pediatric OLT recipients. Thirty-nine percent had no immunity before …
of a total series of 261 pediatric OLT recipients. Thirty-nine percent had no immunity before …
Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome
RD Holmes, K Orban-Eller, FR Karrer, DT Rowe… - …, 2002 - journals.lww.com
Background. Posttransplant lymphoproliferative disease (PTLD) is a serious complications
after liver transplantation. Epstein-Barr virus (EBV) load measured by quantitative …
after liver transplantation. Epstein-Barr virus (EBV) load measured by quantitative …
Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant
JP Luby, W Burnett, AR Hull, AJ Ware… - Journal of Infectious …, 1974 - academic.oup.com
Forty-five consecutive recipients of renal transplants have been studied for three to 18
months (average time, 9.5 months). Sera were collected before transplant and at one, two …
months (average time, 9.5 months). Sera were collected before transplant and at one, two …
Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease …
M Green, M Kaufmann, J Wilson… - Clinical infectious …, 1997 - academic.oup.com
A randomized trial was performed to compare the sequential use of 2 weeks of intravenous
ganciclovir (10 mg/[kgrd]) followed by 50 weeks of high-dose oral acyclovir (800 mg/m2 four …
ganciclovir (10 mg/[kgrd]) followed by 50 weeks of high-dose oral acyclovir (800 mg/m2 four …
Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients
F Smets, M Bodeus, P Goubau, R Reding, JB Otte… - Journal of …, 2000 - Elsevier
Background/Aim: Pediatric liver transplant recipients are at high risk of Epstein-Barr virus
infection. However the incidence of clinical symptoms and the graft function at the time of …
infection. However the incidence of clinical symptoms and the graft function at the time of …
相关搜索
- liver transplantation epstein barr
- virus infection epstein barr
- liver transplantation cytomegalovirus infections
- prevention of cytomegalovirus epstein barr
- liver transplantation virus disease
- virus disease prevention of cytomegalovirus
- ganciclovir alone epstein barr
- therapeutic changes epstein barr
- virus infection gastrointestinal manifestations
- oral acyclovir epstein barr
- dna levels epstein barr
- gastrointestinal manifestations epstein barr
- primary infection epstein barr
- liver transplantation virus infection
- cytomegalovirus disease epstein barr
- virus disease epstein barr